Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Restifo

Showing results (31-40 of 260) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2010
Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapyLuca Gattinoni, Yun Ji, Nicholas P Restifo
Current Opinion in Immunology|March 31, 2009
Adoptive T cell therapy of cancerTon N M Schumacher, Nicholas P Restifo
Cell Metabolism|November 10, 2016
Arginine Arms T Cells to Thrive and SurviveRigel J Kishton, Madhusudhanan Sukumar, Nicholas P Restifo
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?Christopher A Klebanoff, Luca Gattinoni, Nicholas P Restifo
Oncoimmunology|October 21, 2016
Targeting Akt in cell transfer immunotherapy for cancerJoseph G Crompton, Madhusudhanan Sukumar, Nicholas P Restifo
Cell Stem Cell|January 8, 2013
Memoirs of a reincarnated T cellJoseph G Crompton, Mahendra Rao, Nicholas P Restifo
Nature Reviews. Cancer|January 30, 2016
Acquired resistance to immunotherapy and future challengesNicholas P Restifo, Mark J Smyth, Alexandra Snyder
Current Opinion in Immunology|April 18, 2006
Programming CD8+ T cells for effective immunotherapyChristian S Hinrichs, Luca Gattinoni, Nicholas P Restifo
Immunological Reviews|December 17, 2013
Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapyJoseph G Crompton, Madhusudhanan Sukumar, Nicholas P Restifo
Science Translational Medicine|April 8, 2010
Pharmacologic induction of CD8+ T cell memory: better living through chemistryLuca Gattinoni, Christopher A Klebanoff, Nicholas P Restifo
Pageof 26

Showing results (31-40 of 260) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2010
Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapyLuca Gattinoni, Yun Ji, Nicholas P Restifo
Current Opinion in Immunology|March 31, 2009
Adoptive T cell therapy of cancerTon N M Schumacher, Nicholas P Restifo
Cell Metabolism|November 10, 2016
Arginine Arms T Cells to Thrive and SurviveRigel J Kishton, Madhusudhanan Sukumar, Nicholas P Restifo
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?Christopher A Klebanoff, Luca Gattinoni, Nicholas P Restifo
Oncoimmunology|October 21, 2016
Targeting Akt in cell transfer immunotherapy for cancerJoseph G Crompton, Madhusudhanan Sukumar, Nicholas P Restifo
Cell Stem Cell|January 8, 2013
Memoirs of a reincarnated T cellJoseph G Crompton, Mahendra Rao, Nicholas P Restifo
Nature Reviews. Cancer|January 30, 2016
Acquired resistance to immunotherapy and future challengesNicholas P Restifo, Mark J Smyth, Alexandra Snyder
Current Opinion in Immunology|April 18, 2006
Programming CD8+ T cells for effective immunotherapyChristian S Hinrichs, Luca Gattinoni, Nicholas P Restifo
Immunological Reviews|December 17, 2013
Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapyJoseph G Crompton, Madhusudhanan Sukumar, Nicholas P Restifo
Science Translational Medicine|April 8, 2010
Pharmacologic induction of CD8+ T cell memory: better living through chemistryLuca Gattinoni, Christopher A Klebanoff, Nicholas P Restifo
Pageof 26